Randomized controlled trial of desflurane vs. sevoflurane in pediatric liver transplant patients
Not Applicable
- Conditions
- Pediatric patients who are scheduled for living donor liver transplantation
- Registration Number
- JPRN-UMIN000022811
- Lead Sponsor
- ational Center for Child Health and Development
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
Not provided
Exclusion Criteria
1) preoperative ICU management; 2) other organ complications caused by diseases other than the present liver illness; 3) allergy to either/both of inhalation anesthetic(s) or halogenated agents; 4) past history of malignant hyperthermia or family history of malignant hyperthermia; 5) metabolic disease; 6) acute liver failure; 7) pulmonary hypertension; 8) respiratory tract symptoms within 2 weeks before surgery; 9) asthma; 10) any cases inappropriate for the trial judged by surgeons or anesthesiologists in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ratio of operating room extubation after pediatric living donor liver transplantation
- Secondary Outcome Measures
Name Time Method 1) Length of postoperative intubation 2) Length of Intensive care unit stay 3) Perioperative blood examination 4) Perioperative vital sign change 5) Perioperative infusion therapy volume 6) Perioperative urine output change 7) Ratio of postoperaitve infection 8) Ratio of postoperative rejection